Community Healthcare Trust (CHCT) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Revenue grew 3.1% year-over-year to $29.6 million in Q3 2024, with normalized quarter-over-quarter growth of 1%.
Owns 198 properties across 35 states, leased to 315 tenants, with a market cap of $512.6 million as of September 30, 2024.
Achieved 37 consecutive quarters of dividend growth and a 48% total shareholder return since inception.
Acquired six properties for $63.9M in the first nine months of 2024, with 91.3% portfolio occupancy and a weighted average lease term of 6.8 years.
Dividend increased to $0.465 per share, marking consecutive quarterly increases since IPO.
Financial highlights
FFO rose to $12.8 million in Q3 2024, up $1.2 million from Q2 2024; FFO per diluted share was $0.48.
AFFO reached $14.6 million, up from $14.3 million in Q2; AFFO per share rose from $0.53 to $0.55.
Q3 2024 net income was $1.7M, down 49.9% from $3.5M in Q3 2023; nine-month net loss of $5.0M vs. $3.1M income in 2023.
Property operating expenses increased by $414,000 to $6 million, mainly due to seasonal HVAC and utility costs.
Interest expense rose to $6.3 million, reflecting higher revolver borrowings and a 34.7% year-over-year increase.
Outlook and guidance
Four properties under definitive purchase agreements for $8.8 million expected to close in Q4 2024; seven more under contract for $169.5 million to close through 2027.
Three redevelopment projects expected to commence leases in Q1 2025, adding $750,000+ in annual rent.
Signed term sheet for up to $60 million in dialysis clinic developments at 9.5% expected returns.
Sufficient capital anticipated from asset sales and revolver to fund near-term acquisitions.
Declared Q4 2024 dividend of $0.465 per share, annualized to $1.86.
Latest events from Community Healthcare Trust
- Proxy covers director elections, pay alignment, auditor ratification, and ESG priorities.CHCT
Proxy Filing12 Mar 2026 - Key votes include director elections, executive pay, and auditor ratification for 2026.CHCT
Proxy Filing12 Mar 2026 - Q4 2025 saw 5.6% revenue growth, $14.4M net income, and a raised dividend.CHCT
Q4 202518 Feb 2026 - Revenue up, but net income and FFO/AFFO fell as expenses rose; acquisitions and dividend up.CHCT
Q1 202513 Feb 2026 - Net loss and lower FFO/AFFO in Q2 2024 due to tenant credit issues, but acquisitions and dividend growth continued.CHCT
Q2 20242 Feb 2026 - AFFO and FFO per share declined, but acquisitions and credit facility expansion support growth.CHCT
Q4 202423 Dec 2025 - Healthcare REIT launches $500M shelf, including $300M ATM equity, to fund growth and repay debt.CHCT
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, pay, and auditor; board is independent and compensation is performance-based.CHCT
Proxy Filing1 Dec 2025 - Key votes on directors, executive pay, and auditor set for May 2025 annual meeting.CHCT
Proxy Filing1 Dec 2025